Company / Interest Expense
enGene Holdings Inc. Interest Expense History
FY2022-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$5.0M
FY2023
5-year range
$1.4M / $5.0M
FY2022-FY2023
Trend
+248.1%
vs FY2022
Sector context
#37 of 47
Health Care
What the data says
enGene Holdings Inc.'s interest expense of $5M is lower than 79% of companies in the Health Care sector (FY2023).
Based on SEC 10-K filings.
$5M in FY2023.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 47This company $5.0M Sector average $275.6M
▼
-98.2% below sector average
Key checks
Key Insights
- In FY2023, interest expense increased 248.1% year-over-year.
- Ranks #37 out of 47 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $5.0M | +248.1% |
| FY2022 | $1.4M | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026